Floatz logo

Therapeutic Asset Ratings

534 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Immunoglobulin G1, anti-(human CC chemokine receptor CCR8) (human monoclonal CHS114 ?1-chain), disulfide with human monoclonal CHS114 ?-chain, dimer
Cancer
Coherus Oncology, Inc.P1C (36)
Immunoglobulin G1 [de-451-lysine], anti-(human/Macaca fascicularis/Macaca mulatta/Chlorocebus sabaeus MHC class I chain-related protein MICA/MHC class I chain-related protein MICB) (human-Mus musculus monoclonal CLN-619 ?1-chain), disulfide with human-Mus musculus monoclonal CLN-619 [34-leucine] ?-chain, dimer
Cancer
Cullinan Therapeutics Inc.P1C (36)
Ini-4001
Cancer
Inimmune CorporationP1C (36)
IPH5301
Cancer
Institut Paoli-CalmettesP1C (36)
ism5939
Cancer
InSilico Medicine Hong Kong LimitedP1C (36)
ism6331
Cancer
InSilico Medicine Hong Kong LimitedP1C (36)
jmt106
Cancer
Shanghai JMT-Bio Inc.P1C (36)
jzp341
Cancer
Jazz PharmaceuticalsP1C (36)
jzp898
Cancer
Jazz PharmaceuticalsP1C (36)
kk2269
Cancer
Kyowa Kirin Co., Ltd.P1C (36)
kn052
Cancer
Jiangsu Alphamab Biopharmaceuticals Co., LtdP1C (36)
Larotinib
Cancer
Sunshine Lake Pharma Co., Ltd.P1C (36)
Linperlisib
Cancer
Shanghai YingLi Pharmaceutical Co. Ltd.P1C (36)
Lit-00814
Cancer
LittDD Medicines LtdP1C (36)
lk101
Cancer
Beijing Likang Life Science and Tech Co., Ltd.P1C (36)
LP284
Cancer
Lantern Pharma Inc.P1C (36)
lpm6690176
Cancer
Luye Pharma Group Ltd.P1C (36)
Lunresertib
Cancer
University Health Network, TorontoP1C (36)
ly4050784
Cancer
Eli Lilly and CompanyP1C (36)
ly4066434.
Cancer
Eli Lilly and CompanyP1C (36)
m0324
Cancer
EMD Serono Research & Development Institute, Inc.P1C (36)
m3554
Cancer
EMD Serono Research & Development Institute, Inc.P1C (36)
Maq-001
Cancer
MabQuest SAP1C (36)
mbs8
Cancer
MonTa Biosciences ApSP1C (36)
mg2512
Cancer
Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.P1C (36)
Showing 376 to 400 of 534 assets
PreviousPage 16 of 22Next